홈2269 • HKG
add
우시바이오로직스
전일 종가
$14.30
일일 변동폭
$14.28 - $14.90
52주 변동폭
$10.14 - $47.05
시가총액
614.94억 HKD
평균 거래량
5759.01만
주가수익률
22.62
배당수익률
-
기본 거래소
HKG
시장 뉴스
재무
손익계산서
수익
순이익
| (CNY) | 2024년 6월info | 전년대비 변동 |
|---|---|---|
수익 | 42.87억 | 0.97% |
운영비 | 7.65억 | 21.62% |
순이익 | 7.50억 | -33.86% |
순이익률 | 17.48 | -34.51% |
주당 수익 | — | — |
EBITDA | 12.36억 | -13.32% |
유효 세율 | 11.36% | — |
대차대조표
총자산
총부채
| (CNY) | 2024년 6월info | 전년대비 변동 |
|---|---|---|
현금 및 단기 투자 | 95.29억 | 9.60% |
총자산 | 561.06억 | 7.60% |
총부채 | 114.65억 | -12.46% |
총자기자본 | 446.41억 | — |
발행 주식 | 41.51억 | — |
주가순자산비율 | 1.46 | — |
총자산이익률 | 4.05% | — |
자본이익률 | 4.62% | — |
현금 흐름
순현금흐름
| (CNY) | 2024년 6월info | 전년대비 변동 |
|---|---|---|
순이익 | 7.50억 | -33.86% |
영업 현금 흐름 | 6.51억 | -52.65% |
투자 현금 흐름 | -1.91억 | 75.93% |
자금 조달 현금 흐름 | -7.38억 | -684.70% |
순현금흐름 | -2.58억 | -153.79% |
잉여 현금 흐름 | 3.51억 | 52.56% |
정보
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, and began building out capabilities and facilities required for biologics discovery, development and GMP manufacturing. WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
설립
2010
직원 수
12,435
